Ceftriaxone Sodium 500mg | 15mL Injectable SDV
PFZ-00409733801
Pfizer
-
RX License on File Required to Order
Detail
Antibiotics
Key Features and Benefits
- Broad-Spectrum Efficacy: Effective against numerous bacterial pathogens, including strains resistant to other antibiotics.
- High Potency: The 500mg dose offers significant antibacterial strength, addressing infections rapidly and efficiently.
- Convenient Single-Dose Vial: The 15mL SDV format ensures appropriate dosing, minimizing waste and enhancing safety by reducing exposure risks.
- Flexible Administration: Compatible with both intravenous and intramuscular routes, allowing healthcare professionals to select the most suitable method based on the patient’s condition and needs.
- High Stability and Shelf Life: Ceftriaxone’s stable formulation in SDV ensures a long shelf life, providing reliability and reducing the need for frequent reordering.
Indications
Ceftriaxone is indicated for the treatment of various bacterial infections, including but not limited to:
- Lower respiratory tract infections (e.g., pneumonia)
- Urinary tract infections (UTIs)
- Intra-abdominal infections
- Septicemia
- Skin and soft tissue infections
- Bone and joint infections
- Bacterial meningitis
- Gonorrhea
Administration & Dosage
Route: Intravenous (IV) or Intramuscular (IM) injection
Preparation: Reconstitute the powder with sterile diluent as per specific instructions for IV or IM administration.
Dosage varies based on the severity and location of the infection, patient age, and clinical considerations. A healthcare professional should always determine the exact dosing schedule.
Safety Information
- Contraindications: Patients with a known allergy to cephalosporins should avoid this product.
- Storage: Store at controlled room temperature and keep away from direct sunlight. Use immediately after reconstitution to maintain potency and minimize risk of contamination.
- Precautions: Regular monitoring is recommended for patients with renal or hepatic impairment. Possible interactions with other medications should be evaluated by a healthcare provider.